Review of the management of childhood asthma in <scp>T</scp>asmania

Bereznicki, Bonnie; Norton, Lucy C; Beggs, Sean; Gee, Peter; Bereznicki, Lre

doi:10.1111/jpc.12267

Cited by 3 publications

(7 citation statements)

References 25 publications

(48 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some in vitro experiments have shown that repeated bronchoconstriction induces epithelial cell stress, which may eventually lead to remodeling [ 16 ]. Bereznicki et al have reported that 25.7% of children with asthma in Tasmania, Australia, are treated with LABA [ 17 ]. In the present study, we found that 32.13% of pediatric patients received LABA monotherapy.…”

Section: Discussionmentioning

confidence: 99%

Characteristics of medicine use for children with asthma in China: a nationwide population-based study

Shen

Zeng

et al. 2022

BMC Pediatr

View full text Add to dashboard Cite

Objective To analyze the asthma medication use in Chinese children of different age groups, regions, and levels of cities in China, based on the 2015 Healthcare Insurance Data in China. Methods The China Healthcare Insurance Research Association (CHIRA) database was searched for children from 0 to 14 years old diagnosed as asthma based on the “J45” and “J46” coded in ICD-10. A cross-sectional study design was employed. Results A total of 308,550 children were identified, all of whom were treated under the coverage of healthcare insurance. Among them, 2,468 children were eligible for inclusion in the present study. Compared with the current status of asthma care in European and American countries, under the guidelines for the diagnosis and treatment of asthma in China, the use percentages of ICS and short-acting β2 receptor agonist in children with asthma in China were lower, but the use percentages of oral corticosteroids, long-acting β2 receptor agonist, and theophylline (especially intravenous theophylline) were higher, especially in the Central and West China. Conclusion The asthma medication use was attributed to many factors, thus efforts are still needed to further popularize the GINA programs and China's guidelines for asthma diagnosis and treatment, especially in the Central and West China.

show abstract

Section: Discussionmentioning

confidence: 99%

Characteristics of medicine use for children with asthma in China: a nationwide population-based study

Shen

Zeng

et al. 2022

BMC Pediatr

View full text Add to dashboard Cite

show abstract

“…Alleviating the significant burden of disease attributable to asthma can be achieved by optimising the control of symptoms, a long‐term goal requiring regular medical review, pharmacotherapy and carer education . Shown to play a key role in reducing the severity and duration of acute exacerbations, current guidelines also recommend the provision of an individualised asthma action plan (IAAP) for all asthmatic patients and their carers to guide self‐management efforts …”

mentioning

confidence: 99%

“…Despite internationally proven benefits, rates of IAAP uptake and compliance remain low. Recent Australian studies have reported that 47.3–53% of clinically diagnosed asthmatic children do not own a plan . For parents/carers who do own a plan for their child, rates of non‐adherence range from 30 to 70%, reflecting the complex challenge routine self‐management poses .…”

mentioning

confidence: 99%

“…6 Shown to play a key role in reducing the severity and duration of acute exacerbations, current guidelines also recommend the provision of an individualised asthma action plan (IAAP) for all asthmatic patients and their carers to guide self-management efforts. 1,2,[6][7][8][9][10][11] Despite internationally proven benefits, rates of IAAP uptake and compliance remain low. Recent Australian studies have reported that 47.3-53% of clinically diagnosed asthmatic children do not own a plan.…”

mentioning

confidence: 99%

“…Recent Australian studies have reported that 47.3-53% of clinically diagnosed asthmatic children do not own a plan. 3,11,12 For parents/carers who do own a plan for their child, rates of non-adherence range from 30 to 70%, reflecting the complex challenge routine self-management poses. 13,14 As a chronic condition, a multitude of factors influence non-compliance with paediatric asthma regimens and contribute to disparities in disease outcomes.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Asthmatic children from lower‐income families are less likely to own an individualised asthma action plan

Harrison

Duggan

Preddy

et al. 2019

J Paediatrics Child Health

View full text Add to dashboard Cite

Aim This study aimed to explore the relationship between indicators of socio‐economic status (SES) and prescription of a paediatric individualised asthma action plan (IAAP), as well as compliance with that plan. Methods Between May and September 2017, parents/carers of children aged 2–16 years who presented with acute respiratory symptoms and a prior diagnosis of asthma to the emergency department at one regional and one metropolitan hospital in NSW, Australia, were invited to participate in a questionnaire‐based study. Results A total of 175 eligible participants were identified, of which 113 completed the questionnaire. Eighty‐seven children had been prescribed an IAAP (77%). Forty‐nine parents/carers reported non‐compliance with that plan (56.3%). Children from low‐ to middle‐income families were significantly less likely to have a plan (P = 0.001). Being an only child was associated with greater IAAP compliance (P = 0.007) and better asthma control (P = 0.035). No significant relationship between other indicators of SES and rates of plan ownership or compliance was demonstrated. Conclusion Although relatively high in our study sample, IAAP ownership rates remain well below published guidelines. Given the income‐based disparity in plan ownership, physicians must routinely prescribe plans to all asthmatics. Strategies to ensure IAAP ownership and promote their use, especially in the public health sector, would be valuable. Repeating a similar study with a larger sample size will allow more robust conclusions to be drawn regarding the impact of parental SES on compliance.

show abstract

A snapshot of pharmacist attitudes and behaviors surrounding the management of pediatric asthma

et al. 2015

View full text Add to dashboard Cite

show abstract

Review of the management of childhood asthma in Tasmania

Cited by 3 publications

References 25 publications

Characteristics of medicine use for children with asthma in China: a nationwide population-based study

Characteristics of medicine use for children with asthma in China: a nationwide population-based study

Asthmatic children from lower‐income families are less likely to own an individualised asthma action plan

A snapshot of pharmacist attitudes and behaviors surrounding the management of pediatric asthma

Contact Info

Product

Resources

About